Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
August 10, 2020 3:51 PM EDTInovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
... More


